Toru Naganuma, Antonio Colombo, Maciej Lesiak, Davide Capodanno, Tommaso Gori, Holger Nef, Giuseppe Caramanno, Christoph Naber, Carlo Di Mario, Neil Ruparelia, Piera Capranzano, Jens Wiebe, Aleksander Araszkiewicz, Salvatore Geraci, Hiroyoshi Kawamoto, Stelios Pyxaras, Alessio Mattesini, Thomas Münzel, Corrado Tamburino, Azeem Latib
OBJECTIVES: The aim of this study was to evaluate midterm outcomes of bioresorbable vascular scaffolds (BVS) implanted in bifurcation lesions. BACKGROUND: BVS have emerged as an alternative to conventional metallic drug-eluting stents for the treatment of coronary complex lesions. METHODS: Between November 2011 and January 2014, 1189 patients underwent percutaneous coronary intervention with BVS at 10 European centers (GHOST EU registry). Of these, 289 consecutive patients (302 bifurcation lesions) treated with either single-stenting (n = 260) or double-stenting (n = 42) were evaluated...
January 2017: Catheterization and Cardiovascular Interventions